Conclusion »
Author Bios »
The opportunities for advancing oncology diagnoses and
Barbara Geiger, BSN, RNS, EVP
Oncology and Latin America, Clinipace Worldwide
Barbara Geiger has been in the clinical research and development
industry for over 25 years. She is an executive clinical operations
professional with extensive experience in oncology and CNS drug
development.
treatments are great and in demand. To realize the potential,
sufficient and timely enrollment of oncology patients in clinical
trials is paramount. Increasing enrollment can be achieved through
several means, including education of both the lay population and
of cancer patients and their families, intra-network education,
and tools to match studies with patients. Changes toward tailored
therapies and improved study design should help bring about
Christine Mackay, RN, MSA, CCRP
Project Director, Early Phase Pharma, University of Kansas Cancer Center
studies that provide greater chances of benefit for patients.
Chris Mackay is a clinical operations professional with experience
managing global clinical trials in numerous therapeutic areas.
References »
1. NCI Cancer Bulletin. Legislative Update: Most States Fall Short of Requirements for
Insurance Coverage of Cancer Clinical Trials. Available at: http://www.cancer.gov/
ncicancerbulletin/011012/page7. Accessed February 26, 2013.
9. Getz K. Clinical Trial Complexity. Available at: http://www.iom.edu/~/media/Files/
Activity%20Files/Quality/VSRT/LST%20Workshop/Presentations/Getz.pdf. Accessed
March 15, 2013.
2. American Cancer Society. Clinical Trials: What You Need to Know. Available at: www.
cancer.org/clinical-trials-what-you-need-to-know-pdf. Accessed February 25, 2013.
10. Getz KA, Campo RA, Kaitin KI. Variability in protocol design complexity by
phase and therapeutic area. Drug Information Journal. 2011;45(4):413-420.
3. Bond MC, Pritchard S. Understanding clinical trials in childhood cancer. Paediatr
Child Health. 2006;11(3):148-150.
4. Taylor N. Tablets for Trials: Will Mobile Tech Make Development Mor HY